Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
Infectious Diseases
Stem Cells
Biotechnology
Health
University
Pharmaceutical
Science
Education
Vanderbilt

More Like This

Business Wire logo

Parse Biosciences GigaLab to Support Mount Sinai Researchers in Generating One of the Largest Alzheimer's and Parkinson’s Single Cell Datasets

Business Wire logo

Parse Launches GigaLab to Scale Single Cell Sequencing to Billions of Cells Annually

Business Wire logo

Parse Biosciences Launches Evercode Mouse BCR to Support Antibody Engineering and Development for Drug Discovery Applications

Business Wire logo

Parse Biosciences Launches Single Cell Immune Profiling Products

Business Wire logo

Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery

Preliminary data from Parse’s chromatin assay showing clustering of mouse brain nuclei based on DNA accessibility profiles. (Graphic: Business Wire)

Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products

Business Wire logo

Parse Biosciences Quadruples Sample Multiplexing Abilities for Evercode WT Mega Kits

Business Wire logo

Pioneering Cancer Plasticity Atlas will Help Predict Response to Cancer Therapies

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us